Accuray Director Mika Nishimura Vests 1,415 RSUs Following 1-for-40 Reverse Stock Split
Accuray Inc. director Mika Nishimura recently vested 1,415 restricted stock units (RSUs), converting them into common stock shares on November 13, 2026. This transaction, which occurred at no cost, increased Nishimura's direct holdings to 6,731 shares, adjusted for the company's 1-for-40 reverse stock split on November 9, 2026. The details were disclosed in a Form 4 filing with the SEC on November 17, 2026.
An 8% annual dividend accrues on preferred shares behind TCW's Accuray (ARAY) stake.
TCW reports a significant 34% stake in Accuray (ARAY) through Series A Preferred Stock. These preferred shares were issued at $1,000 each, involved a cash investment and cancellation of indebtedness, and come with an 8% annual dividend. TCW also gains the right to designate up to two directors to Accuray's board.
Form SCHEDULE 13D/A ACCURAY INC Filed by: TCW GROUP INC
TCW Group Inc. filed an Amendment No. 4 to its Schedule 13D/A regarding its beneficial ownership in Accuray Inc. This amendment details changes in TCW's holdings, including the issuance of Series A Preferred Stock and the cancellation of certain warrants. TCW Group now holds shared voting and dispositive power over 1,547,950 shares of Accuray Common Stock, representing approximately 34.0% of the class.
Weekly Recap: 1-for-40 reverse stock split and seven-member board
Accuray Incorporated (NASDAQ:ARAY) completed a 1-for-40 reverse stock split on November 9, 2026. Following this transaction, the company reduced its board of directors from eight members to seven, with TCW potentially appointing two directors and independent director Randy Meier joining in October 2026.
Form 8K Accuray Incorporated For: 13 November By Investing.com
This article from Investing.com announces that Accuray Incorporated filed a Form 8K on November 13. The brief notice highlights the filing and its potential relevance to investors. The article itself provides minimal detail beyond the announcement, serving mainly as a headline notification.
Accuray (ARAY) Completes TCW Deal, Reduces Debt and Adds Capital
Accuray (ARAY) has finalized a financing agreement with TCW, which has resulted in debt reduction, the addition of new capital, and the waiver of certain financial covenants until December 31, 2027. This move is part of the company's "Transformation Phase II" plan, initially outlined in July 2026. While the specific amounts for debt reduction and new capital were not disclosed, the transaction is expected to improve the company's financial standing and provide operational flexibility.
Accuray Closes TCW Transaction, Strengthening Balance Sheet to Support Long-Term Value Growth
Accuray Incorporated announced the completion of its financing transaction with TCW Asset Management Company LLC. This deal significantly reduces Accuray's debt by exchanging $40 million of term loan for convertible preferred stock, adds $15 million in new equity, and waives certain financial covenants through December 31, 2027. The transaction strengthens Accuray's balance sheet, supporting its Transformation Phase II strategy to advance innovation, lower costs, and expand market reach.
ARAY: Accuray Incorporated filed SEC Form 8-K: Unregistered Sales...
Accuray Incorporated (ARAY) has filed an SEC Form 8-K detailing unregistered sales of equity securities and a material modification to rights of security holders. The company closed a financing deal with TCW, its largest shareholder, which reduced debt by $40 million, added $15 million in cash, and waived certain financial covenants through December 31, 2027. The deal involved the sale of 55,000 Series A preferred shares for $55 million and included a 1-for-40 reverse stock split for common shares.
Accuray Inc (XEJ.HA) interactive stock chart
This Yahoo Finance page provides an interactive stock chart for Accuray Inc (XEJ.HA), displaying its performance and offering various viewing ranges. It also includes recent news related to the company, such as its TCW transaction, Q1 2027 earnings, reverse stock split, and financial results. The stock closed at 0.0781 EUR, up 3.58% on November 6th.
Accuray Inc (XEJ.HM) stock price, news, quote and history
This page provides an overview of Accuray Inc (XEJ.HM) stock, including its current price, historical data, and performance metrics. As of November 6th at 9:51:18 am GMT+1, the stock was trading at 0.0781 EUR, up 3.58%. The page also details key financial highlights, valuation measures, and comparative returns against the S&P 500.
Accuray Inc (XEJ.HM) interactive stock chart – Yahoo Finance
This Yahoo Finance page provides an interactive stock chart and financial information for Accuray Inc (XEJ.HM), which recently announced a 1-for-40 reverse stock split effective November 9, 2026. The page also lists recent news articles regarding the company's fiscal Q1 2027 earnings, inducement awards, and collaborations. As of the close on November 6, Accuray Inc (XEJ.HM) was trading at 0.0781 EUR, up 3.58%.
Accuray Inc (XEJ.HA) latest stock news and headlines
Accuray Inc (XEJ.HA) stock is trading at 0.0781, up 3.58%, as of November 6, 2026, and recently announced a 1-for-40 reverse stock split effective November 9, 2026. Recent news includes Q1 2027 earnings call highlights, reporting fiscal results, and stockholder approval of financing-related proposals. The company's year-to-date and 1-year returns are significantly down, while the S&P 500 shows positive returns.
A $10.1M profit contrasts with a widening operating loss at Accuray (ARAY).
Accuray Incorporated reported a net income of $10.134 million for the three months ended September 30, 2026, a significant improvement from a $21.678 million loss in the prior year, primarily due to a $59.563 million gain on debt extinguishment. Despite this, the company's operating loss widened to $36.502 million, and total revenue decreased to $86.523 million from $93.942 million year-over-year. The report also detailed a recapitalization transaction and a goodwill impairment charge of $35.392 million.
Accuray Q1FY27 Results: Revenue down 8% YoY as China headwinds persist
Accuray reported an 8% year-over-year decline in net revenue to $86.5 million for Q1 FY27, primarily due to geopolitical challenges in China. Despite this, the company achieved a positive adjusted EBITDA of $2.5 million, a significant improvement from a $4.1 million loss in the prior year, driven by a 4% increase in service revenue and a 25% reduction in operating expenses. Product revenue fell 26%, and the book-to-bill ratio of 0.7 indicates ongoing pressure on future hardware sales.
Accuray Q1 2027 Earnings Call Transcript
Accuray reported an 8% decline in Q1 fiscal 2027 net revenue to $86.5 million, primarily due to geopolitical factors impacting product sales in China, while service revenue grew by 4%. The company is focusing on execution, strategic partnerships for adaptive radiation therapy and imaging, and operational cost reductions to drive future profitability. Accuray also strengthened its financial position with a $15 million cash investment and a debt-to-equity exchange.
Accuray approves 1-for-40 reverse stock split effective Nov. 9
Accuray Incorporated's Board of Directors has approved a 1-for-40 reverse stock split, effective November 9, 2026, at 12:02 a.m. Eastern Time. This action is intended to raise the per-share trading price of its common stock to meet Nasdaq's minimum bid price requirement. The split will reduce outstanding shares from approximately 120.2 million to 3.0 million, with fractional shares paid in cash.
Accuray approves 1-for-40 reverse stock split effective Nov. 9 By Investing.com
Accuray Incorporated announced a 1-for-40 reverse stock split of its common stock, effective November 9, 2026, at 12:02 a.m. Eastern Time. This action is intended to increase the per-share trading price to regain compliance with Nasdaq's minimum bid price requirement. The split will reduce outstanding shares from approximately 120.2 million to 3.0 million, with fractional shares being cashed out.
Accuray Incorporated (ARAY) Approves 1-for-40 Reverse Split to Address Nasdaq Listing Compliance
Accuray Incorporated (ARAY) has approved a 1-for-40 reverse stock split, effective November 9, 2026, to address Nasdaq's minimum bid-price compliance requirements. This action will reduce the number of outstanding shares from approximately 120.2 million to 3.0 million and authorized shares from 400.0 million to 10.0 million. The company emphasizes that this is a corporate action for compliance and does not change percentage ownership for shareholders, aside from fractional-share treatment.
Accuray Announces 1-for-40 Reverse Stock Split
Accuray Incorporated announced a 1-for-40 reverse stock split and a proportional decrease in authorized shares, effective November 9, 2026. This action is intended to raise the per-share trading price of its common stock to meet Nasdaq's minimum bid price requirement. The split will reduce outstanding shares from approximately 120.2 million to 3.0 million, with fractional shares being cashed out.
Form 4 Accuray Incorporated: Michael John Murphy (VP, Corporate Controller) For: 31 October
This article reports on a Form 4 filing for Accuray Incorporated, detailing insider transactions by Michael John Murphy, the VP, Corporate Controller, for October 31. The report indicates a transaction involving the company's stock, identified by the ticker ARAY.
Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results
Accuray Incorporated reported its financial results for the fourth quarter and full fiscal year 2026, ending June 30, 2026. The company highlighted that its transformation plan exceeded targets, delivering over $20 million in cost and margin improvements, and announced a comprehensive financing transaction to strengthen liquidity. Despite a decrease in total net revenue and product revenue, service revenue increased, and the company is not providing formal guidance for fiscal 2027 due to ongoing geopolitical and macroeconomic uncertainties.
Accuray Incorporated (ARAY) Seasonal returns chart
The article provides a seasonal returns chart for Accuray Incorporated (ARAY), showing its average monthly price return from 2016 to 2026. It includes current stock price data and links to various financial information for ARAY.
Accuray Inc (XEJ.SG) Seasonal returns chart
The article provides a seasonal returns chart for Accuray Inc (XEJ.SG), displaying the average monthly price return for the period between 2016 and 2026. It shows the stock's performance with a current quote of 0.1238 EUR, up 1.89%.
Press Release: Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
Accuray Incorporated has reported an inducement award of restricted stock units (RSUs) to its new Senior Vice President and Chief Commercial Officer, Jean-Philippe Latour, as required by NASDAQ Listing Rule 5635(c)(4). The award comprises 100,000 RSUs, which will vest over four years subject to continued employment, and was approved by the company's Board of Directors. This grant was made as an inducement material to Mr. Latour's acceptance of employment.
Accuray (ARAY.US) will release its earnings report after the market close on November 4.
Accuray (ARAY.US) is scheduled to release its earnings report after the market closes on November 4. This announcement provides investors with advance notice to prepare for the company's upcoming financial disclosure. The specific details of the earnings report will be made public after the market's close on that day.
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
Accuray Incorporated has reported an equity inducement award to Sofiane Laoussadi, its new Senior Vice President, Global Services & Solutions, as required by NASDAQ Listing Rules. The award, effective October 30, 2026, includes 650,000 restricted stock units and 650,000 performance-based restricted stock units. These awards are outside the company's current equity plan but subject to similar terms, with vesting contingent on continued service and performance criteria.
ARAY Q1'27 Earnings: revenue estimate is 95.80M USD
Accuray Incorporated (ARAY) is scheduled to release its Q1'27 earnings on November 4, after the market closes, with an expected disclosure at 4:05 PM ET (9:05 PM UTC). Analysts estimate revenue for the quarter to be $95.80 million USD and an EPS of ($0.07) USD. The article provides a table detailing reported and estimated revenue and EPS for several quarters, along with surprise percentages.
Accuray Incorporated Estimates – NASDAQ:ARAY
This article provides an overview of Accuray Incorporated (NASDAQ: ARAY) financial estimates and actuals on TradingView. It allows users to explore reported financial data and analyst estimates across various financial statements and valuation metrics. The platform enables comparison of actual results with average, high, and low estimates, and visualization of trends over time for both annual and quarterly data.
Accuray to Report First Quarter Fiscal 2027 Financial Results on November 4, 2026
Accuray Incorporated (NASDAQ: ARAY) will report its first-quarter fiscal year 2027 financial results on November 4, 2026, via a conference call and live webcast. The call will be hosted by company management at 1:30 p.m. PT/4:30 p.m. ET. Accuray, headquartered in Madison, Wisconsin, is a company focused on advancing radiation therapy solutions for oncology and neuro-radiosurgery.
Accuray to Report First Quarter Fiscal 2027 Financial Results on November 4, 2026
Accuray Incorporated (ARAY) will report its first quarter fiscal year 2027 financial results on November 4, 2026, during a conference call at 1:30 p.m. PT/4:30 p.m. ET. Investors can access the call via dial-in numbers or a live webcast on the company's investor relations website, with replays available for one week. The company, headquartered in Madison, Wisconsin, specializes in radiation therapy solutions for oncology and neuro-radiosurgery.
Form 4 Accuray Incorporated: Ali Pervaiz (SVP Chief Financial Officer) For: 23 September
This article reports on a Form 4 filing for Accuray Incorporated, detailing an insider transaction by Ali Pervaiz, the Senior Vice President and Chief Financial Officer. The filing pertains to activities on September 23. It provides a brief update on this specific financial disclosure without further details.
Form 4 Accuray Incorporated: Ali Pervaiz (SVP Chief Financial Officer) For: 23 September
This article reports on a Form 4 filing for Accuray Incorporated concerning Ali Pervaiz, the SVP Chief Financial Officer, for transactions on September 23. The Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a material change in the holdings of company insiders. The specific details of the transaction are not provided in this brief announcement.
Form 4 Accuray Incorporated: Ali Pervaiz (SVP Chief Financial Officer) For: 23 September
This article reports on a Form 4 filing for Accuray Incorporated, detailing an insider transaction by Ali Pervaiz, the SVP Chief Financial Officer, dated September 23. It briefly states the company name and the officer involved in the filing.
Form DEF 14A ACCURAY INCORPORATED For: 16 October By Investing.com
This article reports on the filing of Form DEF 14A by Accuray Incorporated for October 16. It includes general stock market data, commodity prices, and bond yields, alongside a listing of popular articles and market movers. The primary focus is the regulatory filing for Accuray.
ACCURAY INC SEC Filing (Oct 16, 2026)
This article announces an SEC filing by ACCURAY INC (ARAY) on October 16, 2026. The filing is of type ARS, was accepted by the SEC EDGAR at 04:36 PM EDT, and is available as a PDF document. The article also provides recent news and SEC filings related to Accuray.
Bonus targets went unmet at Accuray (ARAY), but its CEO received a minimum cash award.
Accuray's fiscal year 2026 bonus plan received 0% funding because all three performance measures (orders, revenue, and adjusted EBITDA margin) fell below their minimum thresholds. Despite this, CEO Steve La Neve and Senior VP Paul Miele received minimum cash incentive awards of $262,500 and $87,000, respectively, as stipulated in their employment agreements. The company's compensation philosophy emphasizes pay-for-performance, with a significant portion of executive compensation tied to variable cash incentives and equity awards, aiming to align executive interests with stockholder value creation.
Form DEF 14A ACCURAY INC For: Nov 19
ACCURAY INC has filed its definitive proxy statement (DEF 14A) for its annual meeting of stockholders to be held virtually on November 19, 2026, at 11:00 a.m. CT. The agenda includes the election of one Class II director, an advisory vote on executive compensation, and the ratification of Grant Thornton LLP as the independent registered public accounting firm. The document provides detailed information on executive compensation, director qualifications, and corporate governance practices, emphasizing pay-for-performance and aligning executive interests with stockholders.
Form 8-K ACCURAY INC For: Oct 08
ACCURAY INCORPORATED filed a Form 8-K on October 8, 2026, to report that Mika Nishimura, a Class II director and Chairperson of the Compensation Committee, will not seek re-election at the company's annual meeting in November 2026. Her decision was not due to any disagreement with the company or its board. The filing was signed by David Shin, Senior Vice President, Chief Legal Officer, and Corporate Secretary, on October 13, 2026.
Mika Nishimura to Leave Accuray Board After 2026 Annual Meeting
Mika Nishimura, a Class II Director at Accuray (ARAY) and Chairperson of its Compensation Committee, will not seek re-election and will depart the board after the company's 2026 annual meeting in November. She will continue to serve as a director and Compensation Committee Chair until her departure. Her decision is not due to any disagreements with the company or its board.
Form 4 Accuray Incorporated For: 10 October By Investing.com
This article announces the filing of Form 4 for Accuray Incorporated, pertaining to activity on October 10. It is a brief report from Investing.com, providing basic information about the SEC filing. The company's stock symbol, ARAY, is mentioned with a daily performance figure.
Form 4 Accuray Incorporated For: 10 October By Investing.com
This article from Investing.com reports on a Form 4 filing for Accuray Incorporated, pertaining to October 10. The filing indicates insider transactions for the company, which is identified by the stock symbol ARAY and showed a -4.97% change. The content also briefly mentions other trending market news and data.
Form 4 Accuray Incorporated For: 10 October By Investing.com
This article reports on a Form 4 filing for Accuray Incorporated on October 10. Form 4 documents are filed with the SEC whenever there is a material change in the holdings of company insiders. The article includes the stock symbol ARAY and notes a -4.97% change.
Accuray Announces Stockholder Approval of Key
The article "Accuray Announces Stockholder Approval of Key" reports on Accuray's recent stockholder meeting where key proposals were approved. The specific nature of these key proposals is not detailed in the provided content. This approval signifies a significant step for the company as it moves forward with its strategic initiatives.
Accuray Director Richard Meier Awarded 75,000 RSUs and Stock Options in October 2026
Accuray Director Richard A. Meier was granted 75,000 restricted stock units (RSUs) and 75,000 non-qualified stock options on October 5, 2026, as revealed in a Form 4 filing with the SEC. Both awards vest in three equal annual installments starting one year from the grant date. Following these transactions, Meier directly holds 75,000 RSUs and 75,000 stock options in Accuray Inc (NASDAQ:ARAY).
Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director
Accuray has announced that its stockholders have approved key financing-related proposals. Additionally, the company has appointed a new independent director to its board. This news highlights significant corporate governance and financial developments for Accuray.
Accuray appoints Richard A. Meier to Board and Compensation Committee
Accuray has appointed Richard A. Meier as a Class II director to its Board and to the Compensation Committee, effective October 5, 2026. His compensation includes an annual cash retainer of $30,000, initial RSUs and options, and annual grants of RSUs and options with vesting acceleration on a change in control. This appointment was disclosed in an SEC filing on October 6, 2026.
Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director
Accuray Incorporated announced that its stockholders approved key financing-related proposals, enabling the company to complete transactions with TCW Asset Management Company LLC. These transactions aim to strengthen Accuray's financial position, provide liquidity, and enhance flexibility through a debt-for-equity exchange, an equity investment, and a potential reverse stock split. Additionally, Richard A. ("Randy") Meier has been appointed as a new independent director to the company's board.
Accuray Incorporated Announces Appointment of Richard A. ("Randy") Meier as Director and Compensation Committee Member, Effective October 6, 2026
Accuray Incorporated has announced the appointment of Richard A. ("Randy") Meier to its board of directors and Compensation Committee, effective October 6, 2026. Mr. Meier brings over 30 years of executive leadership experience in the healthcare and medical technology sectors, including prior CEO and CFO roles. His expertise spans transformational growth initiatives, strategic acquisitions, and operational restructurings across global healthcare organizations.
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform
Accuray and Samsung NeuroLogica are advancing their collaboration to integrate volumetric imaging capabilities into the CyberKnife® System, aiming to enhance treatment efficiency and decision-making in radiation oncology. This partnership combines Samsung NeuroLogica's expertise in mobile CT with Accuray's precision treatment delivery. Leading clinicians highlight the potential for improved visualization of patient anatomy and adaptive treatment, reinforcing the importance of this innovation for various cancer treatments.
XEJ Forecast — Price Target — Prediction for 2027
This article provides an overview of Accuray Incorporated (XEJ) stock, traded on the Hannover Stock Exchange. It covers financial metrics like earnings per share, revenue, net income, and EBITDA, along with future earnings and revenue estimates. The company does not pay dividends and has 809 employees as of October 6, 2026.